Skip to main content
Journal ArticleOPEN ACCESS

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa

  • Chachanidze V
  • Curbelo-Irizarry A
  • Ashcraft D
  • et al.
Interdisciplinary Perspectives on Infectious Diseases (2009) 2009 1-5
DOI: 10.1155/2009/984934
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In vitro synergy testing using levofloxacin (LVX) plus piperacillin/tazobactam (TZP) was performed by Etest and time-kill assay (TKA) for 31 unique fluoroquinolone-resistant Pseudomonas aeruginosa isolates. The Etest method showed synergy for 9/31 (29%) of isolates, while TKA showed synergy with 14/31 (45%) of isolates. When comparing the Etest method and TKA, concordant results for synergy, antagonism, and indifference were obtained for 24/31 (77%) of the isolates tested.

Cite

CITATION STYLE

APA

Chachanidze, V., Curbelo-Irizarry, A., Ashcraft, D., & Pankey, G. (2009). In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa. Interdisciplinary Perspectives on Infectious Diseases, 2009, 1–5. https://doi.org/10.1155/2009/984934

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free